loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

Technical details about DSSTox_CID_3487, learn more about the structure, uses, toxicity, action, side effects and more

Client Email Product
Menu
2D Structure
1. Also known as: 28797-61-7, Pirenzepinum, Pirenzepina, Pirenzepin, 11-[2-(4-methylpiperazin-1-yl)acetyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one, Pirenzepine (inn)
Molecular Formula
C19H21N5O2
Molecular Weight
351.4  g/mol
InChI Key
RMHMFHUVIITRHF-UHFFFAOYSA-N
FDA UNII
3G0285N20N

An antimuscarinic agent that inhibits gastric secretion at lower doses than are required to affect gastrointestinal motility, salivary, central nervous system, cardiovascular, ocular, and urinary function. It promotes the healing of duodenal ulcers and due to its cytoprotective action is beneficial in the prevention of duodenal ulcer recurrence. It also potentiates the effect of other antiulcer agents such as CIMETIDINE and RANITIDINE. It is generally well tolerated by patients.
1 2D Structure

2D Structure

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one
2.1.2 InChI
InChI=1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)
2.1.3 InChI Key
RMHMFHUVIITRHF-UHFFFAOYSA-N
2.1.4 Canonical SMILES
CN1CCN(CC1)CC(=O)N2C3=CC=CC=C3C(=O)NC4=C2N=CC=C4
2.2 Other Identifiers
2.2.1 UNII
3G0285N20N
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Dihydrochloride, Pirenzepine

2. Gastrotsepin

3. Gastrozepin

4. L-s 519

5. Ls 519

6. Ls-519

7. Ls519

8. Piren Basan

9. Piren-basan

10. Pirenzepin

11. Pirenzepin Ratiopharm

12. Pirenzepin Von Ct

13. Pirenzepin-ratiopharm

14. Pirenzepine Dihydrochloride

15. Pyrenzepine

16. Ulcoprotect

17. Ulgescum

18. Von Ct, Pirenzepin

2.3.2 Depositor-Supplied Synonyms

1. 28797-61-7

2. Pirenzepinum

3. Pirenzepina

4. Pirenzepin

5. 11-[2-(4-methylpiperazin-1-yl)acetyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one

6. Pirenzepine (inn)

7. 11-((4-methyl-1-piperazinyl)acetyl)-5,11-dihydro-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one

8. 11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one

9. Chembl9967

10. 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one

11. 6h-pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-

12. Aci-91

13. Chebi:8247

14. Pirenzepinedihydrochloridemonohydrate

15. 3g0285n20n

16. Ncgc00015836-08

17. Pirenzepinum [inn-latin]

18. Pirenzepina [inn-spanish]

19. Pirenzepine [inn]

20. Dsstox_cid_3487

21. Pirenzepine [inn:ban]

22. Dsstox_rid_77049

23. Dsstox_gsid_23487

24. Mls000069702

25. 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one

26. 6h-pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-

27. 6h-pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]- (8ci,9ci)

28. 6h-pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-

29. Cas-28797-61-7

30. Smr000058502

31. Einecs 249-228-4

32. Ls-519

33. Brn 0628987

34. Unii-3g0285n20n

35. Pirenzepine-[d8]

36. Spectrum_001378

37. Tocris-1071

38. Starbld0016668

39. Pirenzepine [mi]

40. Prestwick0_000129

41. Prestwick1_000129

42. Prestwick2_000129

43. Prestwick3_000129

44. Spectrum2_001417

45. Spectrum3_001453

46. Spectrum4_000437

47. Spectrum5_001344

48. Lopac-p-7412

49. Pirenzepine [vandf]

50. Lopac0_000962

51. Schembl41705

52. Bspbio_000178

53. Bspbio_002945

54. Gtpl328

55. Kbiogr_000794

56. Kbioss_001858

57. Pirenzepine [who-dd]

58. Divk1c_000127

59. Spbio_001494

60. Spbio_002117

61. Bpbio1_000196

62. Cid_185248

63. Dtxsid7023487

64. Bdbm39341

65. Kbio1_000127

66. Kbio2_001858

67. Kbio2_004426

68. Kbio2_006994

69. Kbio3_002445

70. Ninds_000127

71. Hms2089k21

72. Hms3742e07

73. Hms3742g13

74. Bcp12188

75. Tox21_110239

76. Hy-17037a

77. Pdsp1_000965

78. Pdsp2_000949

79. Zinc19632927

80. Akos015969751

81. Tox21_110239_1

82. Ccg-205042

83. Db00670

84. Sdccgsbi-0050935.p004

85. Idi1_000127

86. Ncgc00015836-01

87. Ncgc00015836-02

88. Ncgc00015836-03

89. Ncgc00015836-04

90. Ncgc00015836-05

91. Ncgc00015836-06

92. Ncgc00015836-07

93. Ncgc00015836-09

94. Ncgc00015836-10

95. Ncgc00015836-12

96. Ncgc00015836-19

97. Ncgc00024297-02

98. Ncgc00024297-04

99. Ncgc00024297-05

100. Sbi-0050935.p003

101. Cas-29868-97-1

102. Ab00053603

103. Cs-0013749

104. Ft-0600051

105. Ft-0673943

106. 97p617

107. C07508

108. D08389

109. Ab00053603-08

110. Ab00053603_09

111. L000485

112. Q419550

113. Brd-k89375097-300-05-4

114. Brd-k89375097-300-06-2

115. 11-[2-(4-methylpiperazino)acetyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride

116. 11-[(4-methyl-1-piperazinyl)acetyl]-5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one #

117. 11-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride

118. 11-[2-(4-methyl-piperazin-1-yl)-acetyl]-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one

119. 11-[2-(4-methylpiperazin-1-yl)-acetyl]-5,11-dihydro-6h-pyrido[2,3-b][1,4]benzodiazepin-6-one

120. 11-[2-(4-methylpiperazin-1-yl)acetyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride

121. 11-[2-(4-methylpiperazin-1-yl)ethanoyl]-5h-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride

122. 2-[2-(4-methylpiperazin-1-yl)acetyl]-2,4,9-triazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one

2.4 Create Date
2005-03-25
3 Chemical and Physical Properties
Molecular Weight 351.4 g/mol
Molecular Formula C19H21N5O2
XLogP30.1
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count5
Rotatable Bond Count2
Exact Mass351.16952493 g/mol
Monoisotopic Mass351.16952493 g/mol
Topological Polar Surface Area68.8 Ų
Heavy Atom Count26
Formal Charge0
Complexity534
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
4 Drug and Medication Information
4.1 Drug Indication

For the treatment of peptic ulcer, gastric ulcer, and duodenal ulcer.


5 Pharmacology and Biochemistry
5.1 Pharmacology

Pirenzepine belongs to a group of medications called antispasmodics/anticholinergics. These medications are used to relieve cramps or spasms of the stomach, intestines, and bladder. Pirenzepine is used to treat duodenal or stomach ulcers or intestine problems. It can be used together with antacids or other medicine in the treatment of peptic ulcer. It may also be used to prevent nausea, vomiting, and motion sickness.


5.2 MeSH Pharmacological Classification

Anti-Ulcer Agents

Various agents with different action mechanisms used to treat or ameliorate PEPTIC ULCER or irritation of the gastrointestinal tract. This has included ANTIBIOTICS to treat HELICOBACTER INFECTIONS; HISTAMINE H2 ANTAGONISTS to reduce GASTRIC ACID secretion; and ANTACIDS for symptomatic relief. (See all compounds classified as Anti-Ulcer Agents.)


Muscarinic Antagonists

Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)


5.3 ATC Code

A - Alimentary tract and metabolism

A02 - Drugs for acid related disorders

A02B - Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

A02BX - Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord)

A02BX03 - Pirenzepine


5.4 Mechanism of Action

Pirenzepine is a muscarinic receptor antagonist and binds to the muscarinic acetylcholine receptor. The muscarinic acetylcholine receptor mediates various cellular responses, including inhibition of adenylate cyclase, breakdown of phosphoinositides and modulation of potassium channels through the action of G proteins.


Post Enquiry
POST ENQUIRY